Home Overview Press Room Blog Publications For Students about us
Search

About Inheritable Genetic Modification


The Basic Science

Frequently Asked Questions

Arguments Pro & Con

3-Person IVF

Inheritable genetic modification (IGM, also called germline engineering) means changing the genes passed on to future generations. The genetic changes would be made in eggs, sperm or early embryos; modified genes would appear not only in the person who developed from that gamete or embryo, but also in all succeeding generations. IGM has not been tried in humans. It would be by far the most consequential type of genetic modification as it would open the door to irreversibly altering the human species.

Proposals for inheritable genetic modification in humans combine techniques involving in vitro fertilization (IVF), gene transfer, stem cells and research cloning.



Who's Advising the Government on Human Genetics?by Alice MaynardBioNewsJune 29th, 2015A diversity of voices is needed to hold the UK government accountable, instead of relying upon experts to predict long-term consequences no one can accurately foresee.
Editing Of Human Embryo Genes Raises Ethics Questionsby Britt E. EricksonChemical & Engineering NewsJune 29th, 2015With the promise of gene-editing tools come worries that the technology could be used to create designer babies with enhanced traits, such as higher intelligence or greater beauty.
The Promise and Peril of Crisprby John Lauerman and Caroline ChenBloomberg BusinessweekJune 25th, 2015The "cheap gene-editing method could lead to cures and frankenbabies."
US Congress Moves to Block Human-Embryo Editingby Sara ReardonNature NewsJune 25th, 2015The House appropriations committee has approved a spending bill that would prohibit the FDA from spending money to evaluate research or clinical applications on gene editing on human embryos.
CALL FOR NOMINATIONS: NAS and NAM Initiative on Human Gene Editingby AnnouncementCommittee On Science, Technology, and LawJune 24th, 2015The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing.
CRISPR: Move Beyond Differencesby Charis ThompsonNature CommentJune 24th, 2015Researchers and ethicists need to see past what can seem to be gendered debates when it comes to the governance of biotechnology.
A 250,000-fold Oversight on 3-person IVF Mitochondrial Transfer?by Paul KnoepflerStem Cell BlogJune 23rd, 2015The potential impact of 3-person IVF technology must be multiplied perhaps by 250,000 relative to a change in a single nuclear gene in a fertilized egg.
CRISPR: Science Can't Solve itby Daniel SarewitzNature CommentJune 23rd, 2015Democratically weighing up the benefits and risks of gene editing and artificial intelligence is a political endeavour, not an academic one.
"Jurassic World" and the Dinosaurs at the USDAby Rachel SmolkerTruthoutJune 22nd, 2015The regulations of the US Department of Agriculture are in desperate need of an overhaul if they are to protect the public from the derailing of billions of years of evolution for the purpose of corporate profit-making.
Manipulating the Genome of Human Embryos: Some Unforeseen Effectsby Craig HoldregeThe Nature InstituteJune 22nd, 2015Over and beyond technical issues is the pressing ethical concern: should researchers cross the line into genetically manipulating human embryos?
Displaying 1-10 of 535  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760